The Experts below are selected from a list of 24 Experts worldwide ranked by ideXlab platform

Tetsuo Aramaki - One of the best experts on this subject based on the ideXlab platform.

  • a case of bilateral Rheumatoid Pleuritis successfully treated with tocilizumab
    Modern Rheumatology, 2013
    Co-Authors: Keiko Ohtsuka, Kimihiko Takeuchi, Masatoshi Matsushita, Tetsuo Aramaki
    Abstract:

    The patient was a 77-year-old woman diagnosed as having Rheumatoid arthritis (RA) in 1973. She was initiated on infliximab therapy in addition to methotrexate administration in 2009. The therapeutic response decreased after the fifth dose of infliximab, and the patient developed Rheumatoid Pleuritis due to increased RA disease activity. The therapy was switched from infliximab to tocilizumab, which resulted in amelioration of the arthralgias well as Pleuritis. Our results suggest that tocilizumab is an effective treatment alternative for the treatment of Rheumatoid Pleuritis.

Keiko Ohtsuka - One of the best experts on this subject based on the ideXlab platform.

  • a case of bilateral Rheumatoid Pleuritis successfully treated with tocilizumab
    Modern Rheumatology, 2013
    Co-Authors: Keiko Ohtsuka, Kimihiko Takeuchi, Masatoshi Matsushita, Tetsuo Aramaki
    Abstract:

    The patient was a 77-year-old woman diagnosed as having Rheumatoid arthritis (RA) in 1973. She was initiated on infliximab therapy in addition to methotrexate administration in 2009. The therapeutic response decreased after the fifth dose of infliximab, and the patient developed Rheumatoid Pleuritis due to increased RA disease activity. The therapy was switched from infliximab to tocilizumab, which resulted in amelioration of the arthralgias well as Pleuritis. Our results suggest that tocilizumab is an effective treatment alternative for the treatment of Rheumatoid Pleuritis.

Jorge M Oliver - One of the best experts on this subject based on the ideXlab platform.

  • localized pleural microdeposition of type a amyloid in a patient with Rheumatoid Pleuritis histologic distinction from pleural involvement in systemic amyloidosis
    American Journal of Clinical Pathology, 1993
    Co-Authors: Fred B Smith, Robert B Brown, George Maguire, Jorge M Oliver
    Abstract:

    Decorticated pleural tissue from a 74-year-old man with Rheumatoid arthritis, an exudative pleural effusion, and normal left ventricular function contained microscopic deposits of amyloid A protein, localized to the interface between a deep layer of dense fibrocollagen and a layer of granulation tissue beneath a surface fibrin exudate. Previously reported instances of pleural amyloid deposition have occurred in patients with presumed systemic amyloidosis, and most such effusions are the result of congestive heart failure. This patient had no evidence of systemic amyloidosis, and this case appeared to be an example of an unusual form of localized amyloidosis, so-called periinflammatory amyloidosis A. These observations suggest that amyloid in a pleural biopsy should not be construed per se to be diagnostic of systemic amyloidosis.

Masatoshi Matsushita - One of the best experts on this subject based on the ideXlab platform.

  • a case of bilateral Rheumatoid Pleuritis successfully treated with tocilizumab
    Modern Rheumatology, 2013
    Co-Authors: Keiko Ohtsuka, Kimihiko Takeuchi, Masatoshi Matsushita, Tetsuo Aramaki
    Abstract:

    The patient was a 77-year-old woman diagnosed as having Rheumatoid arthritis (RA) in 1973. She was initiated on infliximab therapy in addition to methotrexate administration in 2009. The therapeutic response decreased after the fifth dose of infliximab, and the patient developed Rheumatoid Pleuritis due to increased RA disease activity. The therapy was switched from infliximab to tocilizumab, which resulted in amelioration of the arthralgias well as Pleuritis. Our results suggest that tocilizumab is an effective treatment alternative for the treatment of Rheumatoid Pleuritis.

Kimihiko Takeuchi - One of the best experts on this subject based on the ideXlab platform.

  • a case of bilateral Rheumatoid Pleuritis successfully treated with tocilizumab
    Modern Rheumatology, 2013
    Co-Authors: Keiko Ohtsuka, Kimihiko Takeuchi, Masatoshi Matsushita, Tetsuo Aramaki
    Abstract:

    The patient was a 77-year-old woman diagnosed as having Rheumatoid arthritis (RA) in 1973. She was initiated on infliximab therapy in addition to methotrexate administration in 2009. The therapeutic response decreased after the fifth dose of infliximab, and the patient developed Rheumatoid Pleuritis due to increased RA disease activity. The therapy was switched from infliximab to tocilizumab, which resulted in amelioration of the arthralgias well as Pleuritis. Our results suggest that tocilizumab is an effective treatment alternative for the treatment of Rheumatoid Pleuritis.